URGN

UROGEN PHARMA LTD

URGN·M96088105·US·Common Stock·Healthcare - Biotechnology-Activist

URGN (UROGEN PHARMA LTD) is held by 98 institutional investors as of Q1 2026. Largest holders: RTW INVESTMENTS, LP ($81.7M), BlackRock, Inc. ($51.2M), TORONTO DOMINION BANK ($47M). Net institutional sentiment: Mixed.

98
Holders
Avg rating(21 Elite)
$496M
Total Value
50% (112)
Fund Consensus
48 buying - 48 selling
URGNSmart Money Verdict
View all
Held by 98 funds
21 elite
Who's Trading
InsiderSMSchoenberg MarkSell $400KJul 9, 2026
InsiderSMSchoenberg MarkSell $350KJun 22, 2026
InsiderSMSchoenberg MarkSell $143KJun 8, 2026
ActivistThe Toronto-Dominion BankThe Toronto-Dominion Bank5.4%May 15, 2026
ActivistPBParadigm BioCapital Advisors LP3.5%May 15, 2026
InsiderSMSchoenberg MarkSell $300KMay 8, 2026
ActivistBlackRock, Inc.BlackRock, Inc.5.2%Apr 27, 2026
InsiderSMSchoenberg MarkSell $250KNov 19, 2025
ActivistCFCowen Financial Products LLC0.0%Nov 14, 2025
InsiderDCDegnan ChrisSell $37KOct 8, 2025
13F: Insider & Congress:
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Unchanged
4.5M$81.7M0.8%+155.23%
0
Increased
2.8M(+9.4%)$51.2M0.0%+225.28%
32
New
2.6M$47M0.1%+104.89%
40
Decreased
2.6M(-0.1%)$46M0.0%+166.81%
0
Unchanged
2.2M$39.5M0.3%+211.23%
0
Increased
1.6M(+20.5%)$29.4M0.0%+71.92%
34
Increased
1.3M(+68.1%)$23.6M0.2%+80.13%
50
Unchanged
1.2M$20.7M0.1%+4.39%
0
Increased
1M(+6.3%)$18.4M0.0%+100.21%
30
Increased
874,176(+8.3%)$15.7M0.0%+150.25%
31
Increased
598,528(+30.2%)$10.8M0.0%+154.59%
35
Increased
523,831(+10.2%)$9.4M0.0%+169.54%
30
Unchanged
500,726$9M0.0%+100.47%
0
New
409,557$7.4M0.0%+104.89%
38
Decreased
387,074(-65.6%)$7M0.0%+66.42%
0
Decreased
370,898(-40.1%)$6.7M0.0%+120.15%
0
Increased
275,938(+16.2%)$5M0.0%+182.32%
31
Decreased
267,996(-63.7%)$4.8M0.0%+145.37%
0
Decreased
236,192(-35.6%)$4.2M0.0%+84.11%
0
Decreased
230,630(-47.0%)$4.1M0.0%+101.46%
0

Showing 1-20 of 112

1 / 6

Other Healthcare stocks held by institutions

Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used